Skip to main content
. 2013 Apr 19;62(6):1073–1082. doi: 10.1007/s00262-013-1403-0

Table 2.

Complete responses in tumor-bearing mice treated with rituximab with or without IL-18

Rituximab dose (mg/kg) Number of mice with complete response/total number of mice treated per group
No IL-18 IL-18 4 mg/kg
0.5 0/6 2/6
1 2/6 4/6
2 2/6 5/6

SCID mice (n = 6 per group) were injected with Ramos cells as described in Materials and Methods and given daily s.c. injections of recombinant murine IL-18 4 mg/kg or vehicle (“No IL-18”) as indicated together with twice weekly i.v. infusions of rituximab in doses of 0.5, 1, or 2 mg/kg as indicated